ECSP003683A - Agonistas del receptor 3(r3) del peptido activador de la adenilato ciclasa de la pituitaria y sus metodos de uso farmacologico - Google Patents
Agonistas del receptor 3(r3) del peptido activador de la adenilato ciclasa de la pituitaria y sus metodos de uso farmacologicoInfo
- Publication number
- ECSP003683A ECSP003683A ECSP003683A ECSP003683A EC SP003683 A ECSP003683 A EC SP003683A EC SP003683 A ECSP003683 A EC SP003683A EC SP003683 A ECSP003683 A EC SP003683A
- Authority
- EC
- Ecuador
- Prior art keywords
- peptides
- insulin
- pituitary
- cycling
- use methods
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 8
- 238000000034 method Methods 0.000 title abstract 3
- 230000003213 activating effect Effects 0.000 title 1
- UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 title 1
- 239000000556 agonist Substances 0.000 title 1
- 230000001351 cycling effect Effects 0.000 title 1
- 230000000144 pharmacologic effect Effects 0.000 title 1
- 230000001817 pituitary effect Effects 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 7
- 229940122199 Insulin secretagogue Drugs 0.000 abstract 2
- 241000124008 Mammalia Species 0.000 abstract 2
- 238000001727 in vivo Methods 0.000 abstract 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract 2
- 230000003914 insulin secretion Effects 0.000 abstract 2
- 229920001184 polypeptide Polymers 0.000 abstract 2
- 210000002237 B-cell of pancreatic islet Anatomy 0.000 abstract 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 1
- 102000004877 Insulin Human genes 0.000 abstract 1
- 108090001061 Insulin Proteins 0.000 abstract 1
- 102000002808 Pituitary adenylate cyclase-activating polypeptide Human genes 0.000 abstract 1
- 108010004684 Pituitary adenylate cyclase-activating polypeptide Proteins 0.000 abstract 1
- 230000003247 decreasing effect Effects 0.000 abstract 1
- 230000001419 dependent effect Effects 0.000 abstract 1
- 208000016097 disease of metabolism Diseases 0.000 abstract 1
- 239000008103 glucose Substances 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 229940125396 insulin Drugs 0.000 abstract 1
- 210000004153 islets of langerhan Anatomy 0.000 abstract 1
- 208000030159 metabolic disease Diseases 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
Esta invención presenta novedosos péptidos que funcionan in vivo para estimular la libreación de insulina de las célñulas beta pancráticas en forma dependiente de la glucosa. Se ha demostrado que estos peptidos secretagogos de insulina estimulan la liberación de insulina en las células de islotes de ratas in vitro e in vivo. Los péptidos de la presente invención proporcionan una nueva terapia para pacientes con secreción de insulina disminuida, en especial diabéticos de tipo 2. En especial, la invención es un polipéptido seleccionado entre un grupo especifico de polipéptidos relacionados con VIP/PACAP, o equivalentes funcionales del mismo. La invención se refiere asi mismo a un método para tratar una enfermedad metabólica en un mamifero que comprende administrar una cantidad terapéuticamente efectiva de los péptidos secretagogos de insulina a dicho mamífero. También se describen métodos para preparar los péptidos, tanto recombinantes como sintéticos.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP003683 ECSP003683A (es) | 2000-09-28 | 2000-09-28 | Agonistas del receptor 3(r3) del peptido activador de la adenilato ciclasa de la pituitaria y sus metodos de uso farmacologico |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP003683 ECSP003683A (es) | 2000-09-28 | 2000-09-28 | Agonistas del receptor 3(r3) del peptido activador de la adenilato ciclasa de la pituitaria y sus metodos de uso farmacologico |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP003683A true ECSP003683A (es) | 2001-09-24 |
Family
ID=42041274
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP003683 ECSP003683A (es) | 2000-09-28 | 2000-09-28 | Agonistas del receptor 3(r3) del peptido activador de la adenilato ciclasa de la pituitaria y sus metodos de uso farmacologico |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP003683A (es) |
-
2000
- 2000-09-28 EC ECSP003683 patent/ECSP003683A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DOP2000000071A (es) | Agonistas del receptor 3 (r3) del peptido activador de la adenilato ciclasa de la pituitaria y sus metodos de uso farmacológico | |
| UY27893A1 (es) | Agonistas del receptor (vpac2) del peptido activante de la adenilatociclasa hipofisaria (pacap) y sus metodos de uso farmacologicos | |
| Crawley et al. | Activity of centrally administered galanin fragments on stimulation of feeding behavior and on galanin receptor binding in the rat hypothalamus | |
| EP0512042B1 (en) | Glp-1 analogs useful for diabetes treatment | |
| DK0699686T3 (da) | Biologisk aktive fragmenter af glukagon-lignende insulinotropisk peptid | |
| DK0489089T3 (da) | Terapeutiske peptider | |
| RU2001136014A (ru) | Агонисты рецептора-3 (r3) пептида-активатора гипофизарной аденилатциклазы(расар) и способы их фармакологического применения | |
| US20130195807A1 (en) | Agonists of growth hormone releasing hormone as effectors for survival and proliferation of pancreatic islets | |
| DOP2002000475A (es) | Peptidos que actuan como agonistas del receptor del glp-1 y como antagonistas del receptor del glucagon y sus metodos de uso farmacológico | |
| BR0305039A (pt) | Uso de compostos que possuem a atividade biológica de peptìdeo vasoativo intestinal para o tratamento da sarcoidose | |
| ECSP003683A (es) | Agonistas del receptor 3(r3) del peptido activador de la adenilato ciclasa de la pituitaria y sus metodos de uso farmacologico | |
| AR025902A1 (es) | Agonistas del receptor 3 (r3) del peptido activador de la adenilato ciclasa de la pituitaria y sus metodos de uso farmacologico | |
| BRPI0507177A (pt) | agonistas (vpac2) do receptor peptìdico de ativação de adenilato ciclase pituitários (pacap) e seus métodos farmacológicos de uso | |
| Markoff et al. | Effects of prolactin and glycosylated prolactin on (pro) insulin synthesis and insulin release from cultured rat pancreatic islets | |
| AR053263A1 (es) | Agonistas del receptor (vpac2) de peptido activador de adenilato ciclasa hipofisaria (pacap) y sus metodos de uso farmacologico | |
| Wada et al. | Effect of a new bombesin receptor antagonist,(E)-alkene bombesin isostere, on amylase release from rat pancreatic acini | |
| Dietrich et al. | Effects of BIM26226, a potent and specific bombesin receptor antagonist, on amylase release and binding of bombesin-like peptides to AR4-2J cells | |
| Gargosky et al. | C-terminal bombesin sequence requirements for binding and effects on protein synthesis in Swiss 3T3 cells | |
| Gaudillere et al. | Huan normal dermal fibroblasts express somatostain receptors | |
| Taminato et al. | Bombesin inhibits insulin release from isolated pancreatic islets of rats in vitro | |
| Habener | The role of pancreatic duodenum homeobox protein-1 in the development of diabetes mellitus | |
| Nakamura et al. | Effects of L-364, 718 on Pancreatic Exocrine and Endocrine Secretion in the Rat | |
| Solcia et al. | Immunocytochemical detection of peptides of the glucagon-secretin-VIP-GIP family in endocrine cells | |
| Coy et al. | Pharmacology of GRF and somatostatin: positive and negative control of GH release | |
| Wolf et al. | Uptake of I-125 radiolabelled dynorphin in glioma cell cultures |